Literature DB >> 28668670

A new class of VMAT-2 inhibitors for tardive dyskinesia.

Christoph U Correll1, Maren Carbon2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28668670     DOI: 10.1016/S2215-0366(17)30279-1

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN: 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  2 in total

Review 1.  Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Marco Solmi; Giorgio Pigato; John M Kane; Christoph U Correll
Journal:  Drug Des Devel Ther       Date:  2018-05-14       Impact factor: 4.162

Review 2.  Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice.

Authors:  Robert A Hauser; Jonathan M Meyer; Stewart A Factor; Cynthia L Comella; Caroline M Tanner; Rose Mary Xavier; Stanley N Caroff; Leslie Lundt
Journal:  CNS Spectr       Date:  2020-11-20       Impact factor: 4.604

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.